Skip to main content

Table 1 Data of stage IB1 to IIA2 patients before and after matching

From: Comparison of survival outcomes between radio-chemotherapy and radical hysterectomy with postoperative standard therapy in patients with stage IB1 to IIA2 cervical cancer: long-term oncological outcome analysis in 37 Chinese hospitals

VariablesUnmatchedMatched
R-CT (n = 582)RH (n = 4308)p-valueR-CT (n = 535)RH (n = 535)p-value
Age (years)55.4 ± 11.248.0 ± 9.70.00054.3 ± 10.154.3 ± 10.01.000
FIGO stage  0.000  1.000
 IB184 (14.4%)2770 (64.3%) 81 (15.1%)81 (15.1%) 
 IB260 (10.3%)322 (7.5%) 56 (10.5%)56 (10.5%) 
 IIA1237 (40.7%)985 (22.9%) 219 (40.9%)219 (40.9%) 
 IIA2201 (34.6%)231 (5.3%) 179 (33.5%)179 (33.5%) 
Histological type  0.000  1.000
 SCC549 (94.3%)3863 (89.7%) 516 (96.4%)516 (96.4%) 
 AC20 (3.5%)341 (7.9%) 11 (2.1%)11 (2.1%) 
 SAC13 (2.2%)104 (2.4%) 8 (1.5%)8 (1.5%) 
Tumour size  0.000  1.000
  > 4 cm292 (50.2%)3404 (79.0%) 268 (50.1%)268 (50.1%) 
  ≤ 4 cm290 (49.8%)904 (21.0%) 267 (49.9%)267 (49.9%) 
  1. R-CT radio-chemotherapy, RH radical hysterectomy with postoperative standard therapy, FIGO International Federation of Gynecology and Obstetrics, SCC squamous cell carcinoma, AC adenocarcinoma, SAC adenosquamous carcinoma